Hahn Confirmation Hearing: Pharma May Be Left Parsing Non-Rx Questions For Policy Clues
US FDA commissioner nominee could face a slew of questions about non-drug issues such as e-cigarette regulation, which may mean pharma must read between the lines for insight into his drug-related policy stances.
